Vantage Consulting Group Inc Bluebird Bio, Inc. Transaction History
Vantage Consulting Group Inc
- $7.31 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding BLUE
# of Institutions
85Shares Held
42.6MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$93.3 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$28.2 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$23.2 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.63MShares$9.85 Million0.05% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.61MShares$9.72 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $466M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...